Kenacort New 0.1% Buccal Paste
Marketer
Abbott
Salt Composition
Triamcinolone Acetonide (0.1% w/w)
Overview Kenacort New 0.1% Buccal Paste
Triamcinolone acetonide 0.1% buccal paste, a corticosteroid medication, treats mouth sores. It reduces swelling and redness in the affected oral area. Apply the paste directly to the lesion as prescribed by your physician. Adhere to the recommended dosage and duration. Wash hands before and after application; avoid swallowing the paste. Complete the entire course of treatment, even if symptoms improve. Refrain from eating, drinking, or smoking for at least 30 minutes post-application. Do not exceed the prescribed treatment period; inform your doctor if no improvement is seen within 2-4 weeks. Generally well-tolerated, minor application site irritation may occur. While unlikely to interact with other oral or injectable medications, discuss prior steroid cream use with your doctor before starting this treatment. Use during pregnancy should only be considered if clearly necessary; consult your doctor for guidance.
Uses of Kenacort New 0.1% Buccal Paste
Life-threatening hypersensitivity| Inflammatory joint disease
Major Benefits of Kenacort New 0.1% Buccal Paste:
Apply this medication topically only. Adhere to your physician's prescribed dosage and treatment schedule. Always consult the product label for application instructions.
Common Side effects of Kenacort New 0.1% Buccal Paste:
- No common side effects seen
- Infection
- Joint pain
- Headache
How to use Kenacort New 0.1% Buccal Paste:
Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application details.
How Kenacort New 0.1% Buccal Paste works:
Acortel 0.1% buccal paste, containing the corticosteroid Kenacort, reduces inflammation and allergic responses by inhibiting the body's production of inflammatory mediators.
SAFETY ADVICE
AlcoholNone
No drug interaction detected.
PregnancyCONSULT YOUR DOCTOR
The use of Kenacort New 0.1% Buccal Paste during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCAUTION
The use of Kenacort New 0.1% Buccal Paste while breastfeeding requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system. Lactation should be suspended.
DrivingNone
No known drug interactions.
KidneyNone
No known drug interactions.
LiverNone
No drug interaction identified.
What if you forget to take Kenacort New 0.1% Buccal Paste :
NA
Facts to Know About Kenacort New 0.1% Buccal Paste
| Label | Value |
|---|---|
| Type of Compound | Corticosteroids |
| Addictive | None. |
| Treatment Category | CUTANEOUS |
| Mechanism of Action | Corticosteroids |




